{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:47:10Z","timestamp":1770482830174,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["30730107"],"award-info":[{"award-number":["30730107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["90913023"],"award-info":[{"award-number":["90913023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Provincial Science Foundation of Jiangsu","award":["BK2007246"],"award-info":[{"award-number":["BK2007246"]}]},{"name":"Provincial Science Foundation of Jiangsu","award":["BK2007716"],"award-info":[{"award-number":["BK2007716"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.clim.2009.11.013","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T15:11:11Z","timestamp":1261062671000},"page":"55-62","source":"Crossref","is-referenced-by-count":44,"title":["Sunitinib impairs the proliferation and function of human peripheral T cell and prevents T-cell-mediated immune response in mice"],"prefix":"10.1016","volume":"135","author":[{"given":"Yanhong","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingqian","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqian","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2009.11.013_bib1","first-page":"7310","article-title":"Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma","volume":"48","author":"Elson","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2009.11.013_bib2","first-page":"54","article-title":"Immune and genetic therapies for advanced renal cell carcinoma","volume":"2","author":"Zisman","year":"2000","journal-title":"Rev. Urol."},{"key":"10.1016\/j.clim.2009.11.013_bib3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/sj.bjc.6602978","article-title":"Targeted therapy for metastatic renal cell carcinoma","volume":"94","author":"Patel","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.clim.2009.11.013_bib4","first-page":"183","article-title":"Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic inteleukin-2: an outcome study","volume":"49","author":"Huland","year":"2003","journal-title":"Folia Biol. (Praha)"},{"key":"10.1016\/j.clim.2009.11.013_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(98)03544-2","article-title":"Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomized controlled trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2009.11.013_bib6","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1200\/JCO.2005.03.6723","article-title":"Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma","volume":"24","author":"Ratain","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clim.2009.11.013_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJMe068263","article-title":"Renal-cell carcinoma\u2013molecular pathways and therapies","volume":"356","author":"Brugarolas","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2009.11.013_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3171\/2008.7.JNS08143","article-title":"Brain magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal cell and breast carcinoma","volume":"111","author":"Hill","year":"2009","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clim.2009.11.013_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1586\/14737140.9.1.115","article-title":"New avenues for second-line treatment of metastatic non-small-cell lung cancer","volume":"9","author":"Gridelli","year":"2009","journal-title":"Expert, Rev. Anticancer Ther."},{"issue":"7 Suppl","key":"10.1016\/j.clim.2009.11.013_bib10","first-page":"F207","article-title":"Angiogenesis targeting in gastro-intestinal cancers","volume":"94","author":"Meric","year":"2007","journal-title":"Bull. Cancer"},{"key":"10.1016\/j.clim.2009.11.013_bib11","first-page":"327","article-title":"In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic\/pharmacodynamic relationship","volume":"9","author":"Mendel","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clim.2009.11.013_bib12","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1182\/blood-2007-02-075945","article-title":"Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses","volume":"111","author":"Hipp","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.11.013_bib13","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1158\/1078-0432.CCR-07-5212","article-title":"Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients","volume":"14","author":"Finke","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clim.2009.11.013_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00395536","article-title":"Acute experimental allergic encephalomyelitis in radiation bone marrow chimeras between high and low susceptible strains of mice","volume":"24","author":"Korngold","year":"1986","journal-title":"Immunogenetics"},{"key":"10.1016\/j.clim.2009.11.013_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2009.163","article-title":"Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2\/STAT5 signaling in acute myelogenous leukemia cells","author":"Nishioka","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.clim.2009.11.013_bib16","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1158\/0008-5472.CAN-08-4709","article-title":"The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies","volume":"69","author":"Ozao-Choy","year":"2009","journal-title":"Cancer Res."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661609008778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661609008778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T18:43:11Z","timestamp":1588790591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661609008778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1521661609008778"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2009.11.013","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}